Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTHEM-TIMI 32: rNAPc2 in Non-ST-Elevation ACS
NCT00116012Phase 2Completed
- Sponsor
- Oruka Therapeutics
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant nematode anticoagulant protein c2 in acute coronary syndrome (ACS), sponsored by Oruka Therapeutics. Started Jun 2005; status: completed.
02
Drugs
recombinant nematode anticoagulant protein c2
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00116012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116012.